| Antagonist activity at CXCR2 in human neutrophils assessed as inhibition of GROalpha-stimulated intracellular calcium mobilization at 50 uM by FLIPR assay - BioAssay Summary The identification of two novel series of formyl peptide receptor 1 (FPR1) antagonists are reported, represented by methionine benzimidazole 6 and diamide 7. Both series specifically inhibited the binding of labelled fMLF to hrFPR1 and selectively antagonized FPR1 function in human neutrophils, making them useful in vitro validation tools for the target. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||
Target Sequence: RecName: Full=C-X-C chemokine receptor type 2; Short=CXC-R2; Short=CXCR-2; AltName: Full=CDw128b; AltName: Full=GRO/MGSA receptor; AltName: Full=High affinity interleukin-8 receptor B; Short=IL-8R B; AltName: Full=IL-8 receptor type 2; AltName: CD_antigen=CD182 Description .. ![]() Comment .. ![]() Gene:CXCR2 Conserved Domain Related Protein 3D Structures Tested Compounds: Description: Title: Discovery of small molecule human FPR1 receptor antagonists. Abstract: The identification of two novel series of formyl peptide receptor 1 (FPR1) antagonists are reported, represented by methionine benzimidazole 6 and diamide 7. Both series specifically inhibited the binding of labelled fMLF to hrFPR1 and selectively antagonized FPR1 function in human neutrophils, making them useful in vitro validation tools for the target. (PMID: 21486695) Categorized Comment ChEMBL Assay Type: Functional ChEMBL Assay Data Source: Scientific Literature ChEMBL Target ID: 10773 ChEMBL target type: Target is a single protein chain Result Definitions
Data Table (Concise) Classification
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||